Skip to main content
. Author manuscript; available in PMC: 2012 Sep 1.
Published in final edited form as: Obstet Gynecol. 2011 Sep;118(3):554–559. doi: 10.1097/AOG.0b013e31822b0991

Table 1.

Baseline characteristics of 180 HIV positive women who reported presence or absence of symptoms over a 4 week period after loop electrosurgical excision procedure (LEEP) for CIN2/3

Characteristic Women who
reported symptoms
post LEEP*
N = 94		 Women who
reported no
symptoms post
LEEP
N = 103		 P-Value
Mean Age (years) ± SD 32.8 ± 0.5 33.2 ± 0.7 0.65
CD4 count/mm3, mean, SD 419 ± 28.7 349 ± 20.9 0.05
WHO stage (%)
1
2
3
4
24.2
27.5
34.1
14.3
17.4
33.7
36.1
12.8		 0.65
Anti-Retroviral Therapy use, N (%) 78.7 87.2 0.13
Duration of ARV use (%)
< 3 months
3–6 months
6–12 months
> 1 year
25.5
8.8
11.8
53.9
27.9
7.0
22.1
43.0		 0.22
Hormonal Contraception use, N (%) 25.8 20.9 0.5
Size of Loop used (%)
<1 × 1 cm
1–2 cm
> 2 cm
1.8
92.7
5.5
2.1
89.6
8.3		 0.5
Lesion greater than 2.5 cm (%) 11.6 14.3 0.65
*

Positive symptoms were defined as bleeding, pain, fever, foul smelling discharge